FrancophonIA/ELRC3.0 huggingface dataset:
English: - Very rarely, medicines of this type cause a combination of fever, faster breathing, sweating, muscle stiffness and drowsiness or sleepiness.
Slovenian: • Zelo redko tovrstna zdravila povzročijo kombinacijo zvišanja telesne temperature, pospešenega dihanja, znojenja, okorelosti mišic in dremavosti ali zaspanosti.
English: Glenmark Pharmaceuticals s.r.o Fibíchova 143, 566 17
Slovenian: Fibíchova 143, 566 17
English: Patients treated with any antipsychotic medicines, including olanzapine, should be monitored regularly for lipids in accordance with utilised antipsychotic guidelines e.g. at baseline, 12 weeks after starting olanzapine treatment and every 5 years thereafter.
Slovenian: Bolnike, zdravljene s katerimkoli antipsihotikom, vključno z zdravilom Olanzapine, moramo redno spremljati glede lipidov, v skladu z znanimi priporočili za antipsihotike, npr. na začetku, 12 tednov po začetku jemanja olanzapina in nato vsakih 5 let.
English: Amenorrhea Breast enlargement Galactorrhea in females
Slovenian: Amenoreja Povečanje dojk Galaktoreja pri ženskah
English: Ventricular tachycardia/fibrillation, sudden death (see section 4.4)11
Slovenian: Prekatna tahikardija/fibril acija, nenadna smrt (glejte poglavje 4.4)11
English: Olanzapine Glenmark has been shown to prevent recurrence of these symptoms in patients with bipolar disorder whose manic episode has responded to olanzapine treatment.
Slovenian: Zdravilo Olanzapin Glenmark dokazano preprečuje ponoven pojav teh simptomov pri bolnikih z bipolarno motnjo, pri katerih se je manična epizoda po zdravljenju z olanzapinom izboljšala.
English: What Olanzapine Glenmark is and what it is used for
Slovenian: Kaj je zdravilo Olanzapin Glenmark in za kaj ga uporabljamo
English: 6 In clinical trials, the incidence of Parkinsonism and dystonia in olanzapine-treated patients was numerically higher, but not statistically significantly different from placebo.
Slovenian: 6V kliničnih preskušanjih je bila incidenca parkinsonizma in distonije pri bolnikih, zdravljenih z olanzapinom, številčno večja, a se ni statistično značilno razlikovala od placeba.
English: This includes any possible side effects not listed in this leaflet See section 4.
Slovenian: Posvetujte se tudi, če opazite katerekoli neželene učinke, ki niso navedeni v tem navodilu Glej točko 4.
English: 70 tablets
Slovenian: 70 tablet
English: Patients gaining ≥7%, ≥15% and ≥25% of their baseline body weight with long-term exposure (at least 48 weeks) were very common (64.4 %, 31.7 % and 12.3 % respectively).
Slovenian: Zvečanje osnovne telesne mase za ≥ 7 %, ≥ 15 % in ≥ 25 % se je pri dolgoročni izpostavljenosti bolnikov (vsaj 48 tednov) pojavljalo zelo pogosto (v 64,4 %, 31,7 % in 12,3 %).
English: What you need to know before you take Olanzapine Glenmark
Slovenian: Kaj morate vedeti, preden boste vzeli zdravilo Olanzapin Glenmark
English: New born infants exposed to antipsychotics (including olanzapine) during the third trimester of pregnancy are at risk of adverse reactions including extrapyramidal and/or withdrawal symptoms that may vary in severity and duration following delivery.
Slovenian: Pri novorojenčkih, ki so bili med tretjim trimesečjem nosečnosti izpostavljeni antipsihotikom (vključno z olanzapinom), obstaja tveganje za pojav neželenih učinkov, vključno z ekstrapiramidnimi in/ali odtegnitvenimi simptomi, katerih jakost in čas trajanja po porodu sta lahko različna.
English: In a single oral dose (10 mg) Positron Emission Tomography (PET) study in healthy volunteers, olanzapine produced a higher 5HT2A than dopamine D2 receptor occupancy.
Slovenian: V študiji pozitronske emisijske tomografije (PET) s posameznim peroralnim odmerkom (10 mg) pri zdravih prostovoljcih je olanzapin povzročil višjo zasedenost 5-HT2A kot dopaminskih D2 receptorjev.
English: Seizures where in most cases a history of seizures or risk factors for seizures were reported11
Slovenian: Epileptični napadi, pri katerih so jih v večini primerov imeli že kdaj prej ali so poročali o dejavnikih tveganja za epileptične napade11
English: Very common symptoms in overdose (> 10 % incidence) include tachycardia, agitation/ aggressiveness, dysarthria, various extrapyramidal symptoms, and reduced level of consciousness ranging from sedation to coma.
Slovenian: Zelo pogosti simptomi pri prevelikem odmerjanju (incidenca > 10 %) vključujejo tahikardijo, vznemirjenost/nasilnost, dizartrijo, različne ekstrapiramidne simptome in motnje zavesti v razponu od sedacije do kome.
English: • Medicines for Parkinson's disease
Slovenian: • zdravila za Parkinsonovo bolezen,
English: Do not stop taking your tablets just because you feel better.
Slovenian: Če ste prenehali jemati zdravilo Olanzapine Glenmark Ne prenehajte jemati tablet samo zato, ker se počutite bolje.
English: - The use of Olanzapine Glenmark in elderly patients with dementia is not recommended as it may have serious side effects.
Slovenian: • Uporaba zdravila OLANZAPINE ni priporočljiva pri starejših bolnikih z demenco, saj lahko povzroči resne neželene učinke.
English: Development or exacerbation of diabetes occasionally associated with ketoacidosis or coma, including some fatal cases (see section 4.4) 11
Slovenian: Razvoj ali poslabšanje sladkorne bolezni, občasno povezane s ketoacidozo ali komo, vključno z nekaj smrtnimi primeri (glejte poglavje 4.4)11
English: If this happens after you have been given Olanzapine Glenmark tell your doctor.
Slovenian: Če se vam to zgodi po tem, ko ste prejeli zdravilo OLANZAPINE , povejte svojemu zdravniku.
English: During treatment with olanzapine in combination with lithium or divalproex, an increase of ≥ 7 % from baseline body weight occurred in 17.4 % of patients during acute treatment (up to 6 weeks).
Slovenian: Med zdravljenjem z olanzapinom v kombinaciji z litijem ali divalproeksom se je pri 17,4 % bolnikov med akutnim zdravljenjem ( do 6 tednov) pojavilo povečanje telesne mase za > 7 % od osnovne.
English: You should swallow the Olanzapine Glenmark tablets whole, with water.
Slovenian: Olanzapine Glenmark tablete pogoltnite cele z vodo.
English: Patients treated with any antipsychotic medicines, including olanzapine, should be observed for signs and symptoms of hyperglycaemia (such as polydipsia, polyuria, polyphagia, and weakness) and patients with diabetes mellitus or with risk factors for diabetes mellitus should be monitored regularly for worsening of glucose control.
Slovenian: Bolnike, zdravljene s katerimkoli antipsihotikom, vključno z zdravilom Olanzapine, moramo opazovati za znake in simptome hiperglikemije (kot so polidipsija, poliurija, polifagija in šibkost) ter redno spremljati bolnike s sladkorno boleznijo ali dejavniki tveganja za sladkorno bolezen glede poslabšanja nadzora glukoze.
English: In a multinational, double-blind, comparative study of schizophrenia, schizoaffective, and related disorders which included 1,481 patients with varying degrees of associated depressive symptoms (baseline mean of 16.6 on the Montgomery-Asberg Depression Rating Scale), a prospective secondary analysis of baseline to endpoint mood score change demonstrated a statistically significant improvement (p= 0.001) favouring olanzapine (- 6.0) versus haloperidol (- 3.1).
Slovenian: V dvojno slepi primerjalni študiji shizofrenije, shizoafektivnih in sorodnih motenj, v kateri je sodelovalo več držav in je vključevala 1481 bolnikov z različnimi stopnjami pridruženih depresivnih simptomov (izhodiščna srednja vrednost 16,6 na Montgomery-Asbergovi lestvici ocenjevanja depresije), je prospektivna sekundarna analiza spremembe od izhodiščne do končne ocene razpoloženja pokazala statistično značilno izboljšanje (p = 0,001) v korist olanzapina (-6,0) v primerjavi s haloperidolom (-3,1).
English: Phenylalanine
Slovenian: Fenilalanin
English: There was a 3-fold increase in CVAE in patients treated with olanzapine compared to patients treated with placebo (1.3 % versus 0.4 %, respectively).
Slovenian: Pri bolnikih, zdravljenih z olanzapinom, je bila 3-krat večja pojavnost CVAE v primerjavi z bolniki, ki so prejemali placebo (1,3 % v primerjavi z 0,4 %).
English: In a second 12-month recurrence prevention study in manic episode patients who achieved remission with a combination of olanzapine and lithium and were then randomised to olanzapine or lithium alone, olanzapine was statistically non-inferior to lithium on the primary endpoint of bipolar recurrence (olanzapine 30.0 %, lithium 38.3 %; p = 0.055).
Slovenian: V drugi 12-mesečni študiji preprečevanja ponovitve bolezni pri bolnikih z manično epizodo, ki so z zdravljenjem s kombinacijo olanzapina in litija dosegli remisijo in so jim nato naključno dodelili prejemanje samo olanzapina ali samo litija, ni bil olanzapin statistično značilno nič slabši kot litij ob primarni končni točki ponovitve bipolarne motnje (olanzapin 30,0 %, litij 38,3 %; p = 0,055).
English: PHARMACEUTICAL FORM AND CONTENTS
Slovenian: FARMACEVTSKA OBLIKA IN VSEBINA tableta
English: - The other ingredients are mannitol (E 421), microcrystalline cellulose, aspartame (E 951), crospovidone, magnesium stearate
Slovenian: Pomožne snovi so manitol (E 421), mikrokristalna celuloza, aspartam (E 951), krospovidon, magnezijev stearat.
English: Date of first authorisation: 03 December 2009 Date of latest renewal: 19 August 2014
Slovenian: Datum pridobitve dovoljenja za promet: 03 December 2009 Datum zadnjega podaljšanja dovoljenja za promet: 19 Avgust 2014
English: Olanzapine Glenmark belongs to a group of medicines called antipsychotics.
Slovenian: Zdravilo Olanzapin Glenmark spada v skupino zdravil, imenovanih antipsihotiki in se uporablja za zdravljenje naslednjih bolezni:
English: Very common: Weight gain 13, elevated triglyceride levels 14, increased appetite.
Slovenian: Zelo pogosti: Povečanje telesne mase13, zvišane ravni trigliceridov14, povečan apetit Pogosti: Zvišane ravni holesterola15
English: Olanzapine Glenmark 20 mg tablets are available in aluminium foil blisters of 28, 35, 56, 70 and 98 tablets
Slovenian: Olanzapin Glenmark 20 mg tablete so na voljo v aluminijastih pretisnih omotih po 28, 35, 56, 70 in 98 tablet.
English: Parkinsonism6 Dyskinesia6
Slovenian: Parkinsonizem6 Diskinezije6
English: The following symptoms may occur in newborn babies, of mothers that have used Olanzapine Glenmark in the last trimester (last three months of their pregnancy): shaking, muscle stiffness and/or weakness, sleepiness, agitation, breathing problems, and difficulty in feeding.
Slovenian: Pri novorojenčkih mater, ki so v zadnjih treh mesecih nosečnosti uporabljale zdravilo Olanzapine Glenmark, se lahko pojavijo naslednji simptomi: tresenje, okornost ali šibkost mišic, zaspanost, nemir, težave z dihanjem in motnje hranjenja.
English: Olanzapine Glenmark 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg are available in aluminium foil blisters of 28, 56, 70 and 98tablets
Slovenian: Olanzapin Glenmark 2,5 mg, 5 mg, 7,5 mg, 10 mg, 15 mg tablete so na voljo v aluminijastih pretisnih omotih po 28, 56, 70 in 98 tablet.
English: How to store Olanzapine Glenmark Contents of the pack and other information
Slovenian: Shranjevanje zdravila Olanzapin Glenmark Vsebina pakiranja in dodatne informacije
English: Blood and the lymphatic system disorders
Slovenian: Bolezni krvi in limfatičnega sistema Eozinofilija
English: - If you have any further questions, ask your doctor or pharmacist.
Slovenian: Če imate dodatna vprašanja, se posvetujte z zdravnikom ali s farmacevtom.
English: If you suddenly stop taking Olanzapine Glenmark, symptoms such as sweating, unable to sleep, tremor, anxiety or nausea and vomiting might occur.
Slovenian: Če nenadno prenehate jemati zdravilo Olanzapine Glenmark, se lahko pojavijo simptomi, kot so znojenje, nespečnost, tresenje, občutek tesnobe ali slabost in bruhanje.
English: • Serious allergic reactions such as Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS).
Slovenian: Zelo redki neželeni učinki vključujejo resne alergijske reakcije, kot je npr. reakcija na zdravilo z eozinofilijo in sistemskimi simptomi (DRESS).
English: A. MANUFACTURER(S) RESPONSIBLE FOR BATCH RELEASE
Slovenian: A. IZDELOVALCI ZDRAVILA, ODGOVORNI ZA SPROŠČANJE SERIJE
English: Glenmark Pharmaceuticals B.V. Tél/Tel: + 31 629 62 4818 / +31 40 245 3611
Slovenian: Tél/Tel: + 31 629 62 4818 / +31 40 245 3611
English: Olanzapine demonstrated a greater in vitro affinity for serotonin 5HT2 than dopamine D2 receptors and greater 5 HT2 than D2 activity in vivo, models.
Slovenian: V pogojih in vitro je olanzapin pokazal večjo afiniteto za serotoninske 5-HT2 kot za dopaminske D2 receptorje in večjo 5-HT2 kot D2 aktivnost v modelih in vivo.
English: • Liver or kidney disease
Slovenian: • obolenje jeter ali ledvic bolezni krvi
English: Abdominal distension9
Slovenian: Trebušna distenzija9
English: Do not drink any alcohol if you have been given Olanzapine Glenmark as together with alcohol it may make you feel drowsy.
Slovenian: Jemanje zdravila Olanzapine Glenmark skupaj z alkoholom Če ste dobili zdravilo Olanzapine Glenmark, ne pijte nobenega alkohola, saj lahko zdravilo Olanzapine Glenmark in alkohol skupaj povzročita občutek zaspanosti.
English: Gastrointestinal disorders Mild, transient anticholinergic effects including constipation and dry mouth
Slovenian: Blagi prehodni antiholinergični učinki, vključno z zaprtjem in suhimi usti
English: Estrous cycles were affected at doses of 1.1 mg/kg (3 times the maximum human dose) and reproduction parameters were influenced in rats given 3 mg/kg (9 times the maximum human dose).
Slovenian: 3 mg/kg (9-kratni maksimalni odmerek za človeka) pa so pri podganah vplivali na parametre reprodukcije.
English: Dizziness Akathisia6
Slovenian: Omotica Akatizija6
English: In placebo-controlled clinical trials (6-12 weeks duration) of elderly patients (mean age 78 years) with dementia-related psychosis and/or disturbed behaviours, there was a 2-fold increase in the incidence of death in olanzapine-treated patients compared to patients treated with placebo (3.5 % vs 1.5 %, respectively).
Slovenian: V kliničnih preskušanjih, kontroliranih s placebom (ki so trajali 6-12 tednov), pri starejših bolnikih s psihozo, povezano z demenco in/ali vedenjskimi motnjami (povprečna starost 78 let), je bilo 2-kratno povečanje incidence smrti pri bolnikih, zdravljenih z olanzapinom, v primerjavi z bolniki, zdravljenimi s placebom (3,5 % v primerjavi z 1,5 %).
English: Following short term treatment (median duration 47 days), weight gain ≥ 7 % of baseline body weight was very common (22.2%), ≥ 15% was common (4.2%) and ≥25% was uncommon (0.8%).
Slovenian: S kratkoročnim zdravljenjem (srednje trajanje 47 dni) povezano zvečanje telesne mase za ≥ 7 % od osnovne telesne mase je bilo zelo pogosto (22,2 %), ≥ 15 % pogosto (4,2 %) in ≥ 25 % občasno (0,8 %).
English: There is a risk of feeling drowsy when you are given Olanzapine Glenmark.
Slovenian: Obstaja tveganje, da se boste po tem, ko ste dobili zdravilo Olanzapine Glenmark, počutili zaspane.
English: 8 In clinical trials of up to 12 weeks, plasma prolactin concentrations exceeded the upper limit of normal range in approximately 30% of olanzapine treated patients with normal baseline prolactin value.
Slovenian: 8V kliničnih preskušanjih, ki so trajala do 12 tednov, so pri 30 % bolnikov z normalno začetno vrednostjo prolaktina, ki so se zdravili z olanzapinom, ugotovili zvišanje plazemske koncentracije prolaktina nad zgornjo mejo normalne vrednosti.
English: Weight should be monitored regularly e.g. at baseline, 4, 8 and 12 weeks after starting olanzapine treatment and quarterly thereafter.
Slovenian: Redno moramo spremljati telesno maso, npr. na začetku, 4, 8 in 12 tednov po začetku jemanja olanzapina in nato enkrat na tri mesece.
English: Transient, asymptomatic elevations of hepatic aminotransferases, alanine transferase (ALT), aspartate transferase (AST) have been seen commonly, especially in early treatment.
Slovenian: Pogosto so opažali prehodna, asimptomatska zvišanja jetrnih aminotransferaz, ALT, AST, posebno na začetku zdravljenja.
English: What Olanzapine Glenmark looks like and contents of the pack Olanzapine Glenmark 2.5mg is supplied as: yellow coloured circular flat bevelled edge tablets with ‘A' debossed on one side.
Slovenian: Izgled zdravila Olanzapin Glenmark in vsebina pakiranja Olanzapin Glenmark 2,5 mg je na voljo kot: rumena, okrogla, ploščata tableta z zaobljenim robom in oznako 'A' na eni strani.
English: Urinary incontinence, urinary retention Urinary hesitation11
Slovenian: Urinska inkontinenca, zastajanje urina Težave z začetkom mokrenja11
English: Photosensitivity reaction Alopecia
Slovenian: Fotosenzitivnostn e reakcije
English: Mannitol (E 421) Microcrystalline cellulose Aspartame (E 951) Crospovidone Magnesium stearate
Slovenian: 6.1 Seznam pomožnih snovi manitol E 421 mikrokristalna celuloza aspartam E 951 krospovidon magnezijev stearat
English: In female versus male subjects the mean elimination half life was somewhat prolonged (36.7 versus 32.3 hrs) and the clearance was reduced (18.9 versus 27.3 l/hr).
Slovenian: Pri ženskah v primerjavi z moškimi je bil srednji razpolovni čas izločanja nekoliko podaljšan (36,7 v primerjavi z 32,3 ure) in očistek zmanjšan (18,9 v primerjavi s 27,3 l/h).
English: 13 Following short term treatment (median duration 22 days), weight gain ≥ 7 % of baseline body weight (kg) was very common (40.6 %), ≥ 15 %of baseline body weight was common (7.1 %) and ≥ 25 % was common (2.5 %).
Slovenian: 13 S kratkotrajnim zdravljenjem (srednje trajanje 22 dni) povezano povečanje telesne mase za ≥ 7 % od osnovne telesne mase (kg) je bilo zelo pogosto (40,6 %), ≥ 15 % pogosto (7,1 %) in za ≥ 25 % občasno (2,5 %).
English: The pharmacokinetics of olanzapine are similar between adolescents and adults.
Slovenian: Mladostniki (stari 13 do17 let): Farmakokinetika olanzapina je podobna pri mladostnikih in odraslih.
English: Elevated cholesterol levels2,3
Slovenian: Zvišane ravni holesterola2,3 Zvišane ravni glukoze4
English: 4 Observed for fasting normal levels at baseline (< 5.56 mmol/l) which increased to high (≥ 7 mmol/l).
Slovenian: 4Opazovano pri osnovnih normalnih ravneh na tešče (< 5,56 mmol/l), ki so se povišale na visoke (≥ 7 mmol/l).
English: Elevated triglyceride levels2,5
Slovenian: Zvišane ravni trigliceridov2,5 Glikozurija Povečan apetit
English: Warnings and precautions Talk to your doctor or pharmacist before you take Olanzapine Glenmark
Slovenian: Opozorila in previdnostni ukrepi Pred začetkom jemanja zdravila OLANZAPINE se posvetujte s svojim zdravnikom ali s farmacevtom.
English: mmol/l) and changes in fasting triglycerides from borderline at baseline (≥ 1.016 mmol/l - < 1.467 mmol/l) to high (≥ 1.467 mmol/l).
Slovenian: (≥ 1,467 mmol/l) in spremembe v ravneh trigliceridov na tešče z mejnih osnovnih vrednosti (≥ 1,016 mmol/l - < 1,467 mmol/l) na visoke (≥ 1,467 mmol/l).
English: Nervous system disorders Somnolence
Slovenian: Bolezni živčevja Zaspanost
English: Pharmacotherapeutic group: psycholeptics, diazepines, oxazepines, thiazepines and oxepines, ATC code N05A H03.
Slovenian: Farmakoterapevtska skupina: psiholeptiki, diazepini, oksazepini, tiazepini in oksepini.
English: Changes in fasting triglycerides from borderline at baseline (≥ 1.69 mmol/l - < 2.26 mmol/l) to high (≥ 2.26 mmol/l) were very common.
Slovenian: Zelo pogoste so bile spremembe v ravneh trigliceridov na tešče z mejnih osnovnih vrednosti (≥ 1,69 mmol/l - < 2,26 mmol/l) na visoke (≥ 2,26 mmol/l).
English: Thrombocytopeni a11
Slovenian: Trombocitopenij a11
English: How to take Olanzapine Glenmark
Slovenian: Kako jemati zdravilo Olanzapine Glenmark
English: If you get any side effects, talk to your doctor or pharmacist.
Slovenian: opazite katerikoli neželeni učinek, se posvetujte s svojim zdravnikom ali s farmacevtom.
English: What Olanzapine Glenmark contains - The active substance is olanzapine - Each Olanzapine Glenmark tablet contains 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg or 20 mg olanzapine
Slovenian: Ena tableta zdravila Olanzapin Glenmark vsebuje 2,5 mg, 5 mg, 7,5 mg, 10 mg, 15 mg ali 20 mg olanzapina.
English: Thromboembolis hypotension10
Slovenian: Ortostatska hipotenzija10
English: Olanzapine Glenmark 7.5 mg: yellow coloured circular flat bevelled edge tablets with ‘C' debossed on one side.
Slovenian: Olanzapin Glenmark 7,5 mg: rumena, okrogla, ploščata tableta z zaobljenim robom in oznako 'C' na eni strani.
English: Neuroleptic malignant syndrome (see section
Slovenian: Nevroleptični maligni sindrom (glejte poglavje 4.4)12O
English: Aluminium/aluminium blisters in cartons of 28, 35, 56, 70 and 98 tablets per carton.
Slovenian: Aluminij/aluminij pretisni omoti v škatlah po 28, 35, 56, 70 ali 98 tablet.
English: 5 Observed for fasting normal levels at baseline (< 1.69 mmol/l) which increased to high (≥ 2.26
Slovenian: 5Opazovano pri osnovnih normalnih ravneh na tešče (< 1,69 mmol/l), ki so se povišale na visoke (≥ 2,26 mmol/l).
English: Gynaecomastia/breast enlargement in males
Slovenian: Ginekomastija/po večanje dojk pri moških
English: NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER Glenmark Arzneimittel GmbH
Slovenian: IME IN NASLOV IMETNIKA DOVOLJENJA ZA PROMET Z ZDRAVILOM Glenmark Arzneimittel GmbH
English: Only take other medicines while you are on Olanzapine Glenmark if your doctor tells you that you can. You might feel drowsy if Olanzapine Glenmark is taken in combination with antidepressants or medicines taken for anxiety or to help you sleep (tranquillisers).
Slovenian: Če jemljete zdravilo Olanzapine Glenmark v kombinaciji z zdravili za zdravljenje depresije, zdravili za zdravljenje občutkov tesnobe ali zdravili, ki vam pomagajo spati (pomirjevala), se lahko počutite zaspani.
English: - High blood sugar and high levels of fat (triglycerides and cholesterol) have been seen in patients taking Olanzapine Glenmark.
Slovenian: • Pri bolnikih, ki so jemali zdravilo OLANZAPINE , so opazili visok nivo sladkorja v krvi in visok nivo maščob (trigliceridov in holesterola).
English: 14 Observed for fasting normal levels at baseline (< 1.016 mmol/l) which increased to high (≥ 1.467
Slovenian: 14 Opazovano pri osnovnih normalnih ravneh na tešče (< 1,016 mmol/l), ki so se povišale na visoke
English: Changes in total fasting cholesterol levels from borderline at baseline (≥ 5.17- < 6.2 mmol/l) to high (≥ 6.2 mmol/l) were very common.
Slovenian: Zelo pogoste so bile spremembe v ravneh celokupnega holesterola na tešče z mejnih osnovnih vrednosti (≥ 5,17 mmol/l - < 6,2 mmol/l) na visoke (≥ 6,2 mmol/l).
English: Aluminium/aluminium blisters in cartons of 28, 56, 70, 98 tablets per carton.
Slovenian: Aluminij/aluminij pretisni omoti v škatlah po 28, 56, 70 ali 98 tablet.
English: 3 Observed for fasting normal levels at baseline (< 5.17 mmol/l) which increased to high (≥ 6.2
Slovenian: 3Opazovano pri osnovnih normalnih ravneh na tešče (< 5,17 mmol/l), ki so se povišale na visoke (≥ 6,2 mmol/l).
English: Metabolism and nutrition disorders Weight gain1
Slovenian: Presnovne in prehranske motnje Povečanje telesne mase1
English: Other medicines and Olanzapine Glenmark
Slovenian: Shranjevanje zdravila Olanzapin Glenmark
English: Olanzapine Glenmark 7.5 mg tablets
Slovenian: Olanzapin Glenmark 7,5 mg tablete
English: Olanzapine Glenmark 20 mg: yellow coloured circular flat bevelled edge tablets with ‘OL' debossed on one side and ‘F' debossed on other side.
Slovenian: Olanzapin Glenmark 20 mg: rumena, okrogla, ploščata tableta z zaobljenim robom, z oznako 'OL' na eni strani in oznako 'F' na drugi strani.
English: Changes in total fasting cholesterol levels from borderline at baseline (≥ 4.39 - < 5.17 mmol/l) to high (≥ 5.17 mmol/l) were very common.
Slovenian: Zelo pogoste so bile spremembe v ravneh celokupnega holesterola na tešče z mejnih osnovnih vrednosti (≥ 4,39 mmol/l< 5,17 mmol/l) na visoke (≥ 5,17 mmol/l).
English: Olanzapine Glenmark 10 mg tablets
Slovenian: Olanzapin Glenmark 10 mg tablete
English: Tablet Yellow coloured circular flat bevelled edge tablets with ‘C' debossed on one side.
Slovenian: tableta Rumene, okrogle, ploščate tablete z zaobljenim robom in oznako 'C' na eni strani.
English: Olanzapine Glenmark 15 mg tablets
Slovenian: Olanzapin Glenmark 15 mg tablete